December 31, 2012 “Intelligence: Late Breaking Lab News”

Share on facebook
Share on twitter
Share on linkedin
Share on print
Share on email

It is likely that the latest lab acquisition by Bio-Reference Laboratories, Inc. (BRLI) is for the purpose of building its new Hispanic laboratory business, called Laboratorio Buena Salud. Earlier this month, BRLI announced an agreement to purchase Meridian Clinical Laboratory Corporation, located in Miami, Florida. It’s a small transaction, with a price of approximately $1.85 million. Meridian was founded in 2000 and 100% of the shares are owned by Maria Acosta. With its acquisition of Meridian Clinical Laboratory, BRLI’s Laboratorio Buena Salud gains a physical presence in Miami and South Florida, a region with a large population of Spanish-speaking people.

STERLING BUYS TWO TOX LABS

Sterling Reference Laboratories, of Tacoma, Washington, has acquired two toxicology lab companies. One is Graham- Massey Analytical Labs, Inc., of Shelton, Connecticut. The other acquired lab is SECON Laboratories of Worcester, Massachusetts. Sterling is a SAMSHA-certified lab and was itself acquired last April by a private equity firm. These acquisitions demonstrate the heightened interest by professional investors in drugs of abuse testing and testing in support of pain management.

TRANSITIONS

  • Ken Cerney is now CEO of Manhattan Labs in New York City, New York. He has served in executive roles at Strand Diagnostics, Laboratory Cor- poration of America and Quest Diagnostics Incorporated.
  • Michael Tarwater is the new Vice President of Information Technology for Atherotech Diagnostics Lab, located in Birmingham, Alabama. Tarwater has held executive positions with MuirLab, DSI Laboratories, and Impact Information Technologies.
  • Sonic Healthcare USA hired Noel Maring for the position of Vice President, Hospital Affliations. Maring’s career includes positions with aLabs, PAML, and Damon Clinical Laboratories.
  • Mark Mylinski has joined Saladax Biomedical, Inc., of Bethlehem, Pennsylvania, as its Chief Commercial officer. He was formerly President and CEO of RedPath Integrated Pathology, Inc., and held positions at Ortho- Clinical Diagnostics and Veridex, LLC, both Johnson & Johnson Companies.

Dark Daily Update

dark_daily_logoHave you caught the latest e-briefings from DARK Daily? If so, then you’d know about…

…the findings of a study that included lab test data on 200,000 people and suggests that fasting may not be needed for cholesterol testing. The study was conducted by the University of Calgary and Calgary Laboratory Services.

You can get the free DARK Daily e-briefings by signing up at www.darkdaily.com.

Comments

Leave a Reply

You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.